Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccination
Abstract The present study aimed to investigate whether the serum biomarkers of immune response orchestrate the seroconversion status in patients with autoimmune diseases (AID) upon planned primary 17DD-YF vaccination. For this purpose a total of 161 individuals were enrolled in a prospective study,...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/9c5915f34bfc4ccc990261a2a3a5549a |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:9c5915f34bfc4ccc990261a2a3a5549a |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:9c5915f34bfc4ccc990261a2a3a5549a2021-12-02T15:52:47ZSerum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccination10.1038/s41598-021-89770-82045-2322https://doaj.org/article/9c5915f34bfc4ccc990261a2a3a5549a2021-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-89770-8https://doaj.org/toc/2045-2322Abstract The present study aimed to investigate whether the serum biomarkers of immune response orchestrate the seroconversion status in patients with autoimmune diseases (AID) upon planned primary 17DD-YF vaccination. For this purpose a total of 161 individuals were enrolled in a prospective study, including patients with Rheumatoid Arthritis (RA = 38), Spondyloarthritis (SpA = 51), Systemic Lupus Erythematosus (SLE = 21) and Sjögren’s Syndrome (SS = 30) along with a group of healthy controls (HC = 21). Analysis of plaque reduction neutralization test (PRNT) titers and seropositivity rates along with the 17DD-YF viremia and serum biomarkers were carried out at distinct time points (D0/D3–4/D5–6/D7/D14–28). The results demonstrated an overall lower PRNT titer and seropositivity rate (170 vs. 448; 77 vs. 95%) in AID as compared to HC, especially in SpA and SLE subgroups. No significant differences were observed in the viremia levels amongst groups. In general, a more prominent serum biomarker response was observed in AID as compared to HC, throughout the timeline kinetics. Remarkably, AID/PRNT(−) exhibited higher levels of several biomarkers at baseline as compared to AID/PRNT+. Moreover, while AID/PRNT(+) exhibited earlier increase in serum biomarkers at D3–4/D5–6, the AID/PRNT(−) displayed higher response at later time points (D7/D14–D28). Of note, a synchronic increase of IFN-γ at the peak of viremia (D5–6) was observed in HC and AID/PRNT(+) groups, whereas a later asynchronous IFN-γ response was reported for AID/PRNT(−) at D7. The biomarker profile tends to deflate at post-vaccination timeline, highlighting a putative immunomodulatory effect of live attenuated 17DD-YF vaccine in AID/PRNT(+), but not in AID/PRNT(−). Altogether these data suggested that inflammatory status prior vaccination, low IFN-γ at viremia peak and the occurrence of asynchronous biomarker storm after 17DD-YF vaccination may orchestrate the lack of neutralizing antibody response γ.Ismael Artur da Costa-RochaKetty Lysie Libardi Lira MachadoAna Carolina Campi-AzevedoAndréa Teixeira-CarvalhoVanessa Peruhype-MagalhãesSheila Maria Barbosa de LimaEmily Hime MirandaGisela Freitas TrindadeThays Zanon CasagrandeSamira Tatiyama MiyamotoSávio Carvalho DeottiRafaela Villa Real BarbosaPriscila Costa Martins RochaErica Vieira SerranoValquiria Garcia DinisSônia Alves GouvêaMaria Bernadete Renoldi de Oliveira GaviLidia Balarini da SilvaRuben Horst DuqueAna Paula Espíndula GianordoliMaria de Fatima BissoliMaria da Penha Gomes GouveaLauro Ferreira da Silva Pinto-NetoAna Paula Neves BurianFrancieli Fontana Sutile Tardetti FantinatoGecilmara Salviato PileggiLicia Maria Henrique da MotaValéria ValimOlindo Assis Martins-FilhoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Ismael Artur da Costa-Rocha Ketty Lysie Libardi Lira Machado Ana Carolina Campi-Azevedo Andréa Teixeira-Carvalho Vanessa Peruhype-Magalhães Sheila Maria Barbosa de Lima Emily Hime Miranda Gisela Freitas Trindade Thays Zanon Casagrande Samira Tatiyama Miyamoto Sávio Carvalho Deotti Rafaela Villa Real Barbosa Priscila Costa Martins Rocha Erica Vieira Serrano Valquiria Garcia Dinis Sônia Alves Gouvêa Maria Bernadete Renoldi de Oliveira Gavi Lidia Balarini da Silva Ruben Horst Duque Ana Paula Espíndula Gianordoli Maria de Fatima Bissoli Maria da Penha Gomes Gouvea Lauro Ferreira da Silva Pinto-Neto Ana Paula Neves Burian Francieli Fontana Sutile Tardetti Fantinato Gecilmara Salviato Pileggi Licia Maria Henrique da Mota Valéria Valim Olindo Assis Martins-Filho Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccination |
| description |
Abstract The present study aimed to investigate whether the serum biomarkers of immune response orchestrate the seroconversion status in patients with autoimmune diseases (AID) upon planned primary 17DD-YF vaccination. For this purpose a total of 161 individuals were enrolled in a prospective study, including patients with Rheumatoid Arthritis (RA = 38), Spondyloarthritis (SpA = 51), Systemic Lupus Erythematosus (SLE = 21) and Sjögren’s Syndrome (SS = 30) along with a group of healthy controls (HC = 21). Analysis of plaque reduction neutralization test (PRNT) titers and seropositivity rates along with the 17DD-YF viremia and serum biomarkers were carried out at distinct time points (D0/D3–4/D5–6/D7/D14–28). The results demonstrated an overall lower PRNT titer and seropositivity rate (170 vs. 448; 77 vs. 95%) in AID as compared to HC, especially in SpA and SLE subgroups. No significant differences were observed in the viremia levels amongst groups. In general, a more prominent serum biomarker response was observed in AID as compared to HC, throughout the timeline kinetics. Remarkably, AID/PRNT(−) exhibited higher levels of several biomarkers at baseline as compared to AID/PRNT+. Moreover, while AID/PRNT(+) exhibited earlier increase in serum biomarkers at D3–4/D5–6, the AID/PRNT(−) displayed higher response at later time points (D7/D14–D28). Of note, a synchronic increase of IFN-γ at the peak of viremia (D5–6) was observed in HC and AID/PRNT(+) groups, whereas a later asynchronous IFN-γ response was reported for AID/PRNT(−) at D7. The biomarker profile tends to deflate at post-vaccination timeline, highlighting a putative immunomodulatory effect of live attenuated 17DD-YF vaccine in AID/PRNT(+), but not in AID/PRNT(−). Altogether these data suggested that inflammatory status prior vaccination, low IFN-γ at viremia peak and the occurrence of asynchronous biomarker storm after 17DD-YF vaccination may orchestrate the lack of neutralizing antibody response γ. |
| format |
article |
| author |
Ismael Artur da Costa-Rocha Ketty Lysie Libardi Lira Machado Ana Carolina Campi-Azevedo Andréa Teixeira-Carvalho Vanessa Peruhype-Magalhães Sheila Maria Barbosa de Lima Emily Hime Miranda Gisela Freitas Trindade Thays Zanon Casagrande Samira Tatiyama Miyamoto Sávio Carvalho Deotti Rafaela Villa Real Barbosa Priscila Costa Martins Rocha Erica Vieira Serrano Valquiria Garcia Dinis Sônia Alves Gouvêa Maria Bernadete Renoldi de Oliveira Gavi Lidia Balarini da Silva Ruben Horst Duque Ana Paula Espíndula Gianordoli Maria de Fatima Bissoli Maria da Penha Gomes Gouvea Lauro Ferreira da Silva Pinto-Neto Ana Paula Neves Burian Francieli Fontana Sutile Tardetti Fantinato Gecilmara Salviato Pileggi Licia Maria Henrique da Mota Valéria Valim Olindo Assis Martins-Filho |
| author_facet |
Ismael Artur da Costa-Rocha Ketty Lysie Libardi Lira Machado Ana Carolina Campi-Azevedo Andréa Teixeira-Carvalho Vanessa Peruhype-Magalhães Sheila Maria Barbosa de Lima Emily Hime Miranda Gisela Freitas Trindade Thays Zanon Casagrande Samira Tatiyama Miyamoto Sávio Carvalho Deotti Rafaela Villa Real Barbosa Priscila Costa Martins Rocha Erica Vieira Serrano Valquiria Garcia Dinis Sônia Alves Gouvêa Maria Bernadete Renoldi de Oliveira Gavi Lidia Balarini da Silva Ruben Horst Duque Ana Paula Espíndula Gianordoli Maria de Fatima Bissoli Maria da Penha Gomes Gouvea Lauro Ferreira da Silva Pinto-Neto Ana Paula Neves Burian Francieli Fontana Sutile Tardetti Fantinato Gecilmara Salviato Pileggi Licia Maria Henrique da Mota Valéria Valim Olindo Assis Martins-Filho |
| author_sort |
Ismael Artur da Costa-Rocha |
| title |
Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccination |
| title_short |
Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccination |
| title_full |
Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccination |
| title_fullStr |
Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccination |
| title_full_unstemmed |
Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccination |
| title_sort |
serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17dd yellow fever vaccination |
| publisher |
Nature Portfolio |
| publishDate |
2021 |
| url |
https://doaj.org/article/9c5915f34bfc4ccc990261a2a3a5549a |
| work_keys_str_mv |
AT ismaelarturdacostarocha serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT kettylysielibardiliramachado serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT anacarolinacampiazevedo serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT andreateixeiracarvalho serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT vanessaperuhypemagalhaes serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT sheilamariabarbosadelima serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT emilyhimemiranda serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT giselafreitastrindade serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT thayszanoncasagrande serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT samiratatiyamamiyamoto serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT saviocarvalhodeotti serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT rafaelavillarealbarbosa serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT priscilacostamartinsrocha serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT ericavieiraserrano serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT valquiriagarciadinis serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT soniaalvesgouvea serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT mariabernadeterenoldideoliveiragavi serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT lidiabalarinidasilva serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT rubenhorstduque serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT anapaulaespindulagianordoli serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT mariadefatimabissoli serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT mariadapenhagomesgouvea serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT lauroferreiradasilvapintoneto serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT anapaulanevesburian serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT francielifontanasutiletardettifantinato serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT gecilmarasalviatopileggi serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT liciamariahenriquedamota serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT valeriavalim serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination AT olindoassismartinsfilho serumbiomarkerprofileorchestratingtheseroconversionstatusofpatientswithautoimmunediseasesuponplannedprimary17ddyellowfevervaccination |
| _version_ |
1718385587324452864 |